The initial randomized, double-blind, placebo-controlled clinical trial evaluated the efficacy and tolerability of Digexin to relieve constipation and improve bowel clearance over 14 days. Forty-eight healthy male and female participants, age 25 to 60, were assigned to one of three study arms: 300mg of Digexin, 500 mg of Digexin, or placebo.
Self-administered questionnaires were assessed and revealed both doses:
- Reduced constipation symptoms
- Improved sense of complete evacuation
- Improved quality of life based on significantly reducing physical and psychological discomfort, worries, and concerns
- Improved sleep quality
NXT USA is in search of early-stage partners to start the process of creating finished products. Further, a second larger clinical trial is currently underway to help validate Digexin’s benefits.
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.